Tower Research Capital (TRC)’s Calumet Specialty Products CLMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $297K | Buy |
8,268
+5,521
| +201% | +$143K | 0.01% | 1311 |
|
|
2025
Q4 | $54.6K | Sell |
2,747
-3,540
| -56% | -$68.1K | ﹤0.01% | 2353 |
|
|
2025
Q3 | $115K | Buy |
6,287
+667
| +12% | +$11K | ﹤0.01% | 1889 |
|
|
2025
Q2 | $88.5K | Sell |
5,620
-969
| -15% | -$12.3K | ﹤0.01% | 2482 |
|
|
2025
Q1 | $83.5K | Buy |
6,589
+4,523
| +219% | +$71K | ﹤0.01% | 1874 |
|
|
2024
Q4 | $45.5K | Buy |
2,066
+730
| +55% | +$15.3K | ﹤0.01% | 2617 |
|
|
2024
Q3 | $23.8K | Buy |
+1,336
| New | +$21.4K | ﹤0.01% | 3144 |
|
|
2024
Q2 | – | Sell |
-5,502
| Closed | -$81.8K | – | 5716 |
|
|
2024
Q1 | $81.8K | Buy |
+5,502
| New | +$87.7K | ﹤0.01% | 1945 |
|
|
2023
Q4 | – | Sell |
-17
| Closed | -$325 | – | 5945 |
|
|
2023
Q3 | $325 | Buy |
+17
| New | +$294 | ﹤0.01% | 5604 |
|
|
2023
Q2 | – | Sell |
-1,689
| Closed | -$29K | – | 6068 |
|
|
2023
Q1 | $29K | Buy |
1,689
+1,301
| +335% | +$23.1K | ﹤0.01% | 3023 |
|
|
2022
Q4 | $7K | Sell |
388
-2,174
| -85% | -$35.1K | ﹤0.01% | 4540 |
|
|
2022
Q3 | $33K | Buy |
2,562
+1,327
| +107% | +$19K | ﹤0.01% | 3519 |
|
|
2022
Q2 | $13K | Buy |
1,235
+231
| +23% | +$3.07K | ﹤0.01% | 4197 |
|
|
2022
Q1 | $14K | Sell |
1,004
-1,526
| -60% | -$22.5K | ﹤0.01% | 3873 |
|
|
2021
Q4 | $33K | Buy |
+2,530
| New | +$31.8K | ﹤0.01% | 3125 |
|
|
2020
Q1 | – | Sell |
-991
| Closed | -$4K | – | 3135 |
|
|
2019
Q4 | $4K | Sell |
991
-610
| -38% | -$2.11K | ﹤0.01% | 2758 |
|
|
2019
Q3 | $6K | Buy |
1,601
+297
| +23% | +$1.27K | ﹤0.01% | 3206 |
|
|
2019
Q2 | $5K | Sell |
1,304
-10,030
| -88% | -$40.1K | ﹤0.01% | 2923 |
|
|
2019
Q1 | $40K | Buy |
11,334
+6,898
| +156% | +$22.9K | ﹤0.01% | 1877 |
|
|
2018
Q4 | $10K | Sell |
4,436
-2,592
| -37% | -$10.7K | ﹤0.01% | 2453 |
|
|
2018
Q3 | $45K | Sell |
7,028
-6,083
| -46% | -$43.2K | ﹤0.01% | 1814 |
|
|
2018
Q2 | $98K | Sell |
13,111
-9,082
| -41% | -$68.3K | 0.01% | 1452 |
|
|
2018
Q1 | $157K | Buy |
22,193
+21,853
| +6,427% | +$161K | 0.01% | 995 |
|
|
2017
Q4 | $3K | Buy |
+340
| New | +$2.83K | ﹤0.01% | 3061 |
|
|
2017
Q3 | – | Sell |
-18,120
| Closed | -$77K | – | 3809 |
|
|
2017
Q2 | $77K | Buy |
18,120
+17,607
| +3,432% | +$70.6K | 0.01% | 576 |
|
|
2017
Q1 | $2K | Sell |
513
-5,174
| -91% | -$20.5K | ﹤0.01% | 2601 |
|
|
2016
Q4 | $23K | Buy |
5,687
+5,612
| +7,483% | +$22.9K | ﹤0.01% | 2007 |
|
|
2016
Q3 | $0 | Buy |
+75
| New | +$386 | ﹤0.01% | 3716 |
|
|
2015
Q4 | – | Sell |
-2,611
| Closed | -$63K | – | 4532 |
|
|
2015
Q3 | $63K | Buy |
+2,611
| New | +$67.8K | 0.01% | 859 |
|
|
2015
Q2 | – | Sell |
-160
| Closed | -$4K | – | 4440 |
|
|
2015
Q1 | $4K | Sell |
160
-70
| -30% | -$1.77K | ﹤0.01% | 3378 |
|
|
2014
Q4 | $5K | Buy |
+230
| New | +$5.99K | ﹤0.01% | 2689 |
|
|
2014
Q3 | – | Sell |
-351
| Closed | -$11K | – | 4456 |
|
|
2014
Q2 | $11K | Buy |
351
+320
| +1,032% | +$9.52K | ﹤0.01% | 2266 |
|
|
2014
Q1 | $1K | Buy |
+31
| New | +$846 | ﹤0.01% | 4118 |
|
Other funds holding CLMT
TSC
WDOM
VCM
AAA
VPM
Tower Research Capital (TRC)'s CLMT Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Calumet Specialty Products (CLMT) stake by 201% in Q1 2026, buying an estimated $143K and bringing the position to 8,268 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #1311.
Tower Research Capital (TRC) first reported a position in CLMT in Q1 2014 and has held it in 33 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.
- Tower Research Capital (TRC) held 8,268 shares of Calumet Specialty Products worth $297K as of Q1 2026.
- Tower Research Capital (TRC) bought 5,521 Calumet Specialty Products shares in Q1 2026, an estimated $143K.
- Calumet Specialty Products made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1311 holding.
- Tower Research Capital (TRC) first reported a position in Calumet Specialty Products in Q1 2014 and has held it in 33 quarters since.
- 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.